Organon & Co Shares Are Trading Lower After the FDA Extended the Target Action Date of Its Review for the Company's Supplemental New Drug Application for Vtama Cream.
Organon & Co Shares Are Trading Lower After the FDA Extended the Target Action Date of Its Review for the Company's Supplemental New Drug Application for Vtama Cream.
Organon & Co股票交易下跌，因FDA延长了对公司Vtama Cream补充新药申请的审查目标行动日期。
Organon & Co Shares Are Trading Lower After the FDA Extended the Target Action Date of Its Review for the Company's Supplemental New Drug Application for Vtama Cream.
Organon & Co股价下跌，因为FDA延长了对该公司Vtama Cream补充新药申请的审查目标行动日期。
资讯热榜
更新时间